MedTrace Logo

Rehabilitation After Acute Coronary Syndrome: a New Telemonitoring Strategy

NCT04942977 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 67

Last updated 2021-06-29

No results posted yet for this study

Summary

Cardiac rehabilitation after an acute coronary syndrome is recognised in the latest guidelines and recommendations published by the major scientific societies as a class I indication. Despite this evidence, the number of patients entering such programmes in Europe is still around 30%. The present study aims to validate a new comprehensive Telerehabilitation System to provide support for cardiac rehabilitation, to optimize it and to test its usefulness in terms of improving adherence to physical exercise and cardiovascular risk parameters.

Conditions

  • Angina, Unstable
  • Non-ST-Segment Elevation Myocardial Infarction (NSTEMI)
  • ST-segment Elevation Myocardial Infarction (STEMI)

Interventions

DEVICE

telemonitoring

The system consists of the following elements: 1. Professional website at the hospital, which allows: * To set up an individualised care plan * To establish the patient's risk profile and targets for improvement. * Long-term monitoring of the evolution of cardiovascular risk factors and events that occurred * Advise the patient on self-management strategies. 2. Mobile application software with the following functions: * Scheduled exercise sessions * Medication reminder * Measurement reminder (weight, blood pressure, heart rate, waist circumference, etc.) * Messages: Inbox folder for system messages and messages generated by professionals for a specific patient or video conference. * Training monitor: guides the patient in the performance of their exercise. * Access to certified health information for patients

OTHER

Centre-based cardiac rehabilitation

The physical activity consisted of a workout routine and aerobic cycling training. Patients are instructed to perform 150 minutes per week of moderate physical activity when the hospital phase finishes.

Sponsors & Collaborators

  • Catcronic Salut SL

    lead OTHER

Principal Investigators

  • Ernesto Dalli Peydró, MD · Hospital Arnau de Vilanova. Valencia

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
72 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-28
Primary Completion
2020-12-07
Completion
2020-12-07

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04942977 on ClinicalTrials.gov